Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Matrix stiffness drives HCC invasion and metastasis via interfering with TRIM21-mediated SCD1 ubiquitination.

Oncogene·2026
Same author

MYDGF promotes pathological and physiological retinal angiogenesis via the Gαi1/3-Gab1-Akt-mTOR signaling.

Nature communications·2026
Same author

Iridium (III) metal complexes induce immunogenic cell death in head and neck cancer cells via endoplasmic reticulum stress.

Journal of inorganic biochemistry·2026
Same author

Neuro-Immune Crosstalk: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets.

MedComm·2026
Same author

Revisiting the role of postoperative adjuvant transarterial chemoembolization in hepatocellular carcinoma: a propensity score matching analysis.

Journal of gastrointestinal oncology·2026
Same author

Virtual simulation system in cataract education for medical undergraduates: a prospective quasi-experimental study.

BMC medical education·2025

相关实验视频

Updated: Jun 16, 2025

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
09:47

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Published on: December 9, 2022

3.4K

人工智能在个性化视网膜疾病管理中的应用

Zi-Ran Zhang1,2, Jia-Jun Li1,2, Ke-Ran Li1,2

  • 1The Affiliated Eye Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.

International journal of ophthalmology
|August 19, 2024
PubMed
概括

人工智能 (AI) 通过分析各种数据来增强视网膜疾病的诊断和治疗. 这篇评论强调了人工智能.

科学领域:

  • 眼科医生 眼科 眼科
  • 医疗信息学 医疗信息学
  • 计算机科学 计算机科学

背景情况:

  • 人工智能 (AI) 对于智能数据分析越来越重要.
  • 人工智能在视网膜疾病识别,诊断和分类方面在眼科中表现出显著的有效性.
  • 人工智能使视网膜疾病的全面映射成为个性化临床预测和治疗的必要条件.

研究的目的:

  • 审查人工智能的最新进展,以预测和指导视网膜疾病的临床诊断和治疗.
  • 为眼科医生提供精确,个性化和高质量的治疗策略.
  • 通过人工智能驱动的洞察来优化治疗结果.

主要方法:

  • 对眼科当前人工智能研究的综述.
  • 在人工智能模型中使用的各种输入数据方法 (表格,文本,基于图像) 的分析.
  • 检查多种数据类型的综合分析,以提高准确性和可靠性.

主要成果:

  • 人工智能有助于个性化预测视网膜疾病的预后,风险和进展.
  • 人工智能支持开发量身定制的干预疗法.
  • 多种数据源的整合提高了人工智能驱动结果的准确性和可靠性.
关键词:
人工智能的人工智能是人工智能.人工智能在眼科中的应用视网膜疾病 视网膜疾病

更多相关视频

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
07:43

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

1.9K
Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

7.8K

相关实验视频

Last Updated: Jun 16, 2025

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
09:47

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Published on: December 9, 2022

3.4K
Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
07:43

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

1.9K
Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

7.8K

结论:

  • 人工智能是推动视网膜疾病诊断和治疗的强大工具.
  • 人工智能驱动的方法在眼科中提供了个性化医疗策略.
  • 本综述综合了关键发现,以指导未来在视网膜护理中的AI应用.